Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: KBV Research | PRODUCT CODE: 1245580

Cover Image

PUBLISHER: KBV Research | PRODUCT CODE: 1245580

Asia Pacific Sciatica Treatment Market Size, Share & Industry Trends Analysis Report By Type, By Distribution Channel, By Drug Class (Non-Steroidal anti-inflammatory, Steroids, Antidepressants and Others), By Country and Growth Forecast, 2022 - 2028

PUBLISHED:
PAGES: 90 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 1500
PDF (Multi User License)
USD 1800
PDF (Corporate User License)
USD 2520

Add to Cart

The Asia Pacific Sciatica Treatment Market would witness market growth of 4.3% CAGR during the forecast period (2022-2028).

The growing popularity of sciatica treatments in the automobile sector, rising consumer desire for more fuel-efficient engines, increasing use of electric cars, and other factors are all contributing to the potential development of the sciatica treatment market during the anticipated period. Researchers involved in creating a new intervention are a driving force behind the acceleration of market expansion. The intense desire for disease-specific innovative treatments further boosts the total market demand for this category. The development of medications used to treat sciatica-related problems is another driving force.

Also, the population has access to various indoor professions because of expanding industry. Because of the increasing burden, the working population spends much time sitting down. Long periods of sitting may cause sciatica to develop or become worse. As a result, the increasing number of people in the workforce may encourage the spread of sciatica treatments. Moreover, sacral and lumbar spinal tumors may cause leg paralysis and sciatic back discomfort. Thus, throughout the scheduled time, the increased incidence of cancer among the population may provide new chances for the sciatica treatment market.

One of the world's fastest-growing aging populations is in China. Due to rising life expectancy and falling birth rates, 28% of China's population is expected to be over 60 by 2040. The creation of age-friendly towns and communities where older people may flourish and continue to make significant contributions to society is essential due to the increasingly aging population. In addition, there is an increase in demand for sciatica therapy in the APAC area due to the region's aging population and growing osteoarthritis prevalence.

The China market dominated the Asia Pacific Sciatica Treatment Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $62,929.5 Thousands by 2028. The Japan market is estimated to grow a CAGR of 3.6% during (2022 - 2028). Additionally, The India market would display a CAGR of 4.9% during (2022 - 2028).

Based on Type, the market is segmented into Chronic, Acute and Others. Based on Distribution Channel, the market is segmented into Retail & Specialty Pharmacies, Hospital Pharmacies and Online Providers. Based on Drug Class, the market is segmented into Non-Steroidal anti-inflammatory, Steroids, Antidepressants and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Johnson & Johnson, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Sorrento Therapeutics, Inc., Alkem Laboratories Ltd., Amneal Pharmaceuticals, Inc., Aurobindo Pharma Limited, Novartis AG, and Cadila Healthcare Ltd. (Zydus Cadila)

Scope of the Study

Market Segments covered in the Report:

By Type

  • Chronic
  • Acute
  • Others

By Distribution Channel

  • Retail & Specialty Pharmacies
  • Hospital Pharmacies
  • Online Providers

By Drug Class

  • Non-Steroidal anti-inflammatory
  • Steroids
  • Antidepressants
  • Others

By Country

  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific

Companies Profiled

  • Abbott Laboratories
  • Johnson & Johnson
  • Teva Pharmaceutical Industries Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Sorrento Therapeutics, Inc.
  • Alkem Laboratories Ltd.
  • Amneal Pharmaceuticals, Inc.
  • Aurobindo Pharma Limited
  • Novartis AG
  • Cadila Healthcare Ltd. (Zydus Cadila)

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Asia Pacific Sciatica Treatment Market, by Type
    • 1.4.2 Asia Pacific Sciatica Treatment Market, by Distribution Channel
    • 1.4.3 Asia Pacific Sciatica Treatment Market, by Drug Class
    • 1.4.4 Asia Pacific Sciatica Treatment Market, by Country
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
      • 2.1.1.1 Market Composition & Scenario
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Asia Pacific Sciatica Treatment Market by Type

  • 3.1 Asia Pacific Chronic Market by Country
  • 3.2 Asia Pacific Acute Market by Country
  • 3.3 Asia Pacific Others Market by Country

Chapter 4. Asia Pacific Sciatica Treatment Market by Distribution Channel

  • 4.1 Asia Pacific Retail & Specialty Pharmacies Market by Country
  • 4.2 Asia Pacific Hospital Pharmacies Market by Country
  • 4.3 Asia Pacific Online Providers Market by Country

Chapter 5. Asia Pacific Sciatica Treatment Market by Drug Class

  • 5.1 Asia Pacific Non-Steroidal anti-inflammatory Market by Country
  • 5.2 Asia Pacific Steroids Market by Country
  • 5.3 Asia Pacific Antidepressants Market by Country
  • 5.4 Asia Pacific Others Market by Country

Chapter 6. Asia Pacific Sciatica Treatment Market by Country

  • 6.1 China Sciatica Treatment Market
    • 6.1.1 China Sciatica Treatment Market by Type
    • 6.1.2 China Sciatica Treatment Market by Distribution Channel
    • 6.1.3 China Sciatica Treatment Market by Drug Class
  • 6.2 Japan Sciatica Treatment Market
    • 6.2.1 Japan Sciatica Treatment Market by Type
    • 6.2.2 Japan Sciatica Treatment Market by Distribution Channel
    • 6.2.3 Japan Sciatica Treatment Market by Drug Class
  • 6.3 India Sciatica Treatment Market
    • 6.3.1 India Sciatica Treatment Market by Type
    • 6.3.2 India Sciatica Treatment Market by Distribution Channel
    • 6.3.3 India Sciatica Treatment Market by Drug Class
  • 6.4 South Korea Sciatica Treatment Market
    • 6.4.1 South Korea Sciatica Treatment Market by Type
    • 6.4.2 South Korea Sciatica Treatment Market by Distribution Channel
    • 6.4.3 South Korea Sciatica Treatment Market by Drug Class
  • 6.5 Singapore Sciatica Treatment Market
    • 6.5.1 Singapore Sciatica Treatment Market by Type
    • 6.5.2 Singapore Sciatica Treatment Market by Distribution Channel
    • 6.5.3 Singapore Sciatica Treatment Market by Drug Class
  • 6.6 Malaysia Sciatica Treatment Market
    • 6.6.1 Malaysia Sciatica Treatment Market by Type
    • 6.6.2 Malaysia Sciatica Treatment Market by Distribution Channel
    • 6.6.3 Malaysia Sciatica Treatment Market by Drug Class
  • 6.7 Rest of Asia Pacific Sciatica Treatment Market
    • 6.7.1 Rest of Asia Pacific Sciatica Treatment Market by Type
    • 6.7.2 Rest of Asia Pacific Sciatica Treatment Market by Distribution Channel
    • 6.7.3 Rest of Asia Pacific Sciatica Treatment Market by Drug Class

Chapter 7. Company Profiles

  • 7.1 Abbott Laboratories
    • 7.1.1 Company Overview
    • 7.1.2 Financial Analysis
    • 7.1.3 Segmental and Regional Analysis
    • 7.1.4 Research & Development Expense
    • 7.1.5 SWOT Analysis
  • 7.2 Johnson & Johnson
    • 7.2.1 Company Overview
    • 7.2.2 Financial Analysis
    • 7.2.3 Segmental &Regional Analysis
    • 7.2.4 Research & Development Expenses
  • 7.3 Teva Pharmaceutical Industries Ltd.
    • 7.3.1 Company Overview
    • 7.3.2 Financial Analysis
    • 7.3.3 Regional Analysis
    • 7.3.4 Research & Development Expenses
  • 7.4 Sun Pharmaceutical Industries Ltd.
    • 7.4.1 Company Overview
    • 7.4.2 Financial Analysis
    • 7.4.3 Regional & Segmental Analysis
    • 7.4.4 Research & Development Expenses
  • 7.5 Sorrento Therapeutics, Inc.
    • 7.5.1 Company Overview
    • 7.5.2 Financial Analysis
    • 7.5.3 Segmental Analysis
    • 7.5.4 Research & Development Expenses
  • 7.6 Alkem Laboratories Ltd.
    • 7.6.1 Company Overview
    • 7.6.2 Financial Analysis
    • 7.6.3 Regional Analysis
    • 7.6.4 Research & Development Expenses
  • 7.7 Amneal Pharmaceuticals, Inc.
    • 7.7.1 Company Overview
    • 7.7.2 Financial Analysis
    • 7.7.3 Segmental
    • 7.7.4 Research & Development Expenses
  • 7.8 Aurobindo Pharma Limited
    • 7.8.1 Company Overview
    • 7.8.2 Financial Analysis
    • 7.8.3 Regional Analysis
    • 7.8.4 Research & Development Expense
  • 7.9 Novartis AG
    • 7.9.1 Company Overview
    • 7.9.2 Financial Analysis
    • 7.9.3 Segmental and Regional Analysis
    • 7.9.4 Research & Development Expense
  • 7.10. Cadila Healthcare Ltd. (Zydus Cadila)
    • 7.10.1 Company Overview
    • 7.10.2 Financial Analysis
    • 7.10.3 Segmental and Regional Analysis
    • 7.10.4 Research & Development Expense

LIST OF TABLES

  • TABLE 1 Asia Pacific Sciatica Treatment Market, 2018 - 2021, USD Thousands
  • TABLE 2 Asia Pacific Sciatica Treatment Market, 2022 - 2028, USD Thousands
  • TABLE 3 Asia Pacific Sciatica Treatment Market by Type, 2018 - 2021, USD Thousands
  • TABLE 4 Asia Pacific Sciatica Treatment Market by Type, 2022 - 2028, USD Thousands
  • TABLE 5 Asia Pacific Chronic Market by Country, 2018 - 2021, USD Thousands
  • TABLE 6 Asia Pacific Chronic Market by Country, 2022 - 2028, USD Thousands
  • TABLE 7 Asia Pacific Acute Market by Country, 2018 - 2021, USD Thousands
  • TABLE 8 Asia Pacific Acute Market by Country, 2022 - 2028, USD Thousands
  • TABLE 9 Asia Pacific Others Market by Country, 2018 - 2021, USD Thousands
  • TABLE 10 Asia Pacific Others Market by Country, 2022 - 2028, USD Thousands
  • TABLE 11 Asia Pacific Sciatica Treatment Market by Distribution Channel, 2018 - 2021, USD Thousands
  • TABLE 12 Asia Pacific Sciatica Treatment Market by Distribution Channel, 2022 - 2028, USD Thousands
  • TABLE 13 Asia Pacific Retail & Specialty Pharmacies Market by Country, 2018 - 2021, USD Thousands
  • TABLE 14 Asia Pacific Retail & Specialty Pharmacies Market by Country, 2022 - 2028, USD Thousands
  • TABLE 15 Asia Pacific Hospital Pharmacies Market by Country, 2018 - 2021, USD Thousands
  • TABLE 16 Asia Pacific Hospital Pharmacies Market by Country, 2022 - 2028, USD Thousands
  • TABLE 17 Asia Pacific Online Providers Market by Country, 2018 - 2021, USD Thousands
  • TABLE 18 Asia Pacific Online Providers Market by Country, 2022 - 2028, USD Thousands
  • TABLE 19 Asia Pacific Sciatica Treatment Market by Drug Class, 2018 - 2021, USD Thousands
  • TABLE 20 Asia Pacific Sciatica Treatment Market by Drug Class, 2022 - 2028, USD Thousands
  • TABLE 21 Asia Pacific Non-Steroidal anti-inflammatory Market by Country, 2018 - 2021, USD Thousands
  • TABLE 22 Asia Pacific Non-Steroidal anti-inflammatory Market by Country, 2022 - 2028, USD Thousands
  • TABLE 23 Asia Pacific Steroids Market by Country, 2018 - 2021, USD Thousands
  • TABLE 24 Asia Pacific Steroids Market by Country, 2022 - 2028, USD Thousands
  • TABLE 25 Asia Pacific Antidepressants Market by Country, 2018 - 2021, USD Thousands
  • TABLE 26 Asia Pacific Antidepressants Market by Country, 2022 - 2028, USD Thousands
  • TABLE 27 Asia Pacific Others Market by Country, 2018 - 2021, USD Thousands
  • TABLE 28 Asia Pacific Others Market by Country, 2022 - 2028, USD Thousands
  • TABLE 29 Asia Pacific Sciatica Treatment Market by Country, 2018 - 2021, USD Thousands
  • TABLE 30 Asia Pacific Sciatica Treatment Market by Country, 2022 - 2028, USD Thousands
  • TABLE 31 China Sciatica Treatment Market, 2018 - 2021, USD Thousands
  • TABLE 32 China Sciatica Treatment Market, 2022 - 2028, USD Thousands
  • TABLE 33 China Sciatica Treatment Market by Type, 2018 - 2021, USD Thousands
  • TABLE 34 China Sciatica Treatment Market by Type, 2022 - 2028, USD Thousands
  • TABLE 35 China Sciatica Treatment Market by Distribution Channel, 2018 - 2021, USD Thousands
  • TABLE 36 China Sciatica Treatment Market by Distribution Channel, 2022 - 2028, USD Thousands
  • TABLE 37 China Sciatica Treatment Market by Drug Class, 2018 - 2021, USD Thousands
  • TABLE 38 China Sciatica Treatment Market by Drug Class, 2022 - 2028, USD Thousands
  • TABLE 39 Japan Sciatica Treatment Market, 2018 - 2021, USD Thousands
  • TABLE 40 Japan Sciatica Treatment Market, 2022 - 2028, USD Thousands
  • TABLE 41 Japan Sciatica Treatment Market by Type, 2018 - 2021, USD Thousands
  • TABLE 42 Japan Sciatica Treatment Market by Type, 2022 - 2028, USD Thousands
  • TABLE 43 Japan Sciatica Treatment Market by Distribution Channel, 2018 - 2021, USD Thousands
  • TABLE 44 Japan Sciatica Treatment Market by Distribution Channel, 2022 - 2028, USD Thousands
  • TABLE 45 Japan Sciatica Treatment Market by Drug Class, 2018 - 2021, USD Thousands
  • TABLE 46 Japan Sciatica Treatment Market by Drug Class, 2022 - 2028, USD Thousands
  • TABLE 47 India Sciatica Treatment Market, 2018 - 2021, USD Thousands
  • TABLE 48 India Sciatica Treatment Market, 2022 - 2028, USD Thousands
  • TABLE 49 India Sciatica Treatment Market by Type, 2018 - 2021, USD Thousands
  • TABLE 50 India Sciatica Treatment Market by Type, 2022 - 2028, USD Thousands
  • TABLE 51 India Sciatica Treatment Market by Distribution Channel, 2018 - 2021, USD Thousands
  • TABLE 52 India Sciatica Treatment Market by Distribution Channel, 2022 - 2028, USD Thousands
  • TABLE 53 India Sciatica Treatment Market by Drug Class, 2018 - 2021, USD Thousands
  • TABLE 54 India Sciatica Treatment Market by Drug Class, 2022 - 2028, USD Thousands
  • TABLE 55 South Korea Sciatica Treatment Market, 2018 - 2021, USD Thousands
  • TABLE 56 South Korea Sciatica Treatment Market, 2022 - 2028, USD Thousands
  • TABLE 57 South Korea Sciatica Treatment Market by Type, 2018 - 2021, USD Thousands
  • TABLE 58 South Korea Sciatica Treatment Market by Type, 2022 - 2028, USD Thousands
  • TABLE 59 South Korea Sciatica Treatment Market by Distribution Channel, 2018 - 2021, USD Thousands
  • TABLE 60 South Korea Sciatica Treatment Market by Distribution Channel, 2022 - 2028, USD Thousands
  • TABLE 61 South Korea Sciatica Treatment Market by Drug Class, 2018 - 2021, USD Thousands
  • TABLE 62 South Korea Sciatica Treatment Market by Drug Class, 2022 - 2028, USD Thousands
  • TABLE 63 Singapore Sciatica Treatment Market, 2018 - 2021, USD Thousands
  • TABLE 64 Singapore Sciatica Treatment Market, 2022 - 2028, USD Thousands
  • TABLE 65 Singapore Sciatica Treatment Market by Type, 2018 - 2021, USD Thousands
  • TABLE 66 Singapore Sciatica Treatment Market by Type, 2022 - 2028, USD Thousands
  • TABLE 67 Singapore Sciatica Treatment Market by Distribution Channel, 2018 - 2021, USD Thousands
  • TABLE 68 Singapore Sciatica Treatment Market by Distribution Channel, 2022 - 2028, USD Thousands
  • TABLE 69 Singapore Sciatica Treatment Market by Drug Class, 2018 - 2021, USD Thousands
  • TABLE 70 Singapore Sciatica Treatment Market by Drug Class, 2022 - 2028, USD Thousands
  • TABLE 71 Malaysia Sciatica Treatment Market, 2018 - 2021, USD Thousands
  • TABLE 72 Malaysia Sciatica Treatment Market, 2022 - 2028, USD Thousands
  • TABLE 73 Malaysia Sciatica Treatment Market by Type, 2018 - 2021, USD Thousands
  • TABLE 74 Malaysia Sciatica Treatment Market by Type, 2022 - 2028, USD Thousands
  • TABLE 75 Malaysia Sciatica Treatment Market by Distribution Channel, 2018 - 2021, USD Thousands
  • TABLE 76 Malaysia Sciatica Treatment Market by Distribution Channel, 2022 - 2028, USD Thousands
  • TABLE 77 Malaysia Sciatica Treatment Market by Drug Class, 2018 - 2021, USD Thousands
  • TABLE 78 Malaysia Sciatica Treatment Market by Drug Class, 2022 - 2028, USD Thousands
  • TABLE 79 Rest of Asia Pacific Sciatica Treatment Market, 2018 - 2021, USD Thousands
  • TABLE 80 Rest of Asia Pacific Sciatica Treatment Market, 2022 - 2028, USD Thousands
  • TABLE 81 Rest of Asia Pacific Sciatica Treatment Market by Type, 2018 - 2021, USD Thousands
  • TABLE 82 Rest of Asia Pacific Sciatica Treatment Market by Type, 2022 - 2028, USD Thousands
  • TABLE 83 Rest of Asia Pacific Sciatica Treatment Market by Distribution Channel, 2018 - 2021, USD Thousands
  • TABLE 84 Rest of Asia Pacific Sciatica Treatment Market by Distribution Channel, 2022 - 2028, USD Thousands
  • TABLE 85 Rest of Asia Pacific Sciatica Treatment Market by Drug Class, 2018 - 2021, USD Thousands
  • TABLE 86 Rest of Asia Pacific Sciatica Treatment Market by Drug Class, 2022 - 2028, USD Thousands
  • TABLE 87 Key Information - Abbott Laboratories
  • TABLE 88 Key information -Johnson & Johnson
  • TABLE 89 Key Information - Teva Pharmaceuticals Industries Ltd.
  • TABLE 90 Key Information - Sun Pharmaceutical Industries Ltd.
  • TABLE 91 Key Information - Sorrento Therapeutics, Inc.
  • TABLE 92 Key Information - Alkem Laboratories Ltd.
  • TABLE 93 Key Information - Amneal Pharmaceuticals, Inc.
  • TABLE 94 key information - Aurobindo Pharma Limited
  • TABLE 95 Key Information - Novartis AG
  • TABLE 96 Key Information - Cadila Healthcare Ltd.

List of Figures

  • FIG 1 Methodology for the research
  • FIG 2 Swot analysis: Abbott laboratories
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!